Search

everythinglearnresearchcommunity

for

Search:↓

Tumor proteins can both promote and suppress cancer, depending on the situation.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

The revised study on how inflammation affects cancer stem cells was accepted after improving clarity and structure.

The revised manuscript on how inflammation affects cancer stem cells was accepted after addressing issues with clarity and detail.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

The reviewers found the manuscript on inflammation's role in cancer stem cells to be relevant but suggested it needs clarity, more background information, discussion on immune cells' role in tumors, updated references, and grammar corrections.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

The reviewers suggest clarifying and expanding on the role of inflammation in stem cell-related cancer development.

The reviewers suggest major revisions for clarity and inclusion of recent findings on inflammation's role in cancer.

Reviewers suggest clarifying the abstract, adding background on inflammation's effect on cancer, discussing immune cell roles, including counter studies, and correcting grammar.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Lower SMAD2/3 activation predicts more severe skin cancer.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Certain drugs that block specific enzymes can help treat prostate diseases.

Analog 23 is a promising compound for prostate cancer treatment.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

A cat with hair loss and illness was found to have cancer spread from its colon.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.